Blood flow Rate profiling
OtherBlood flow rate profiling during dialysis session
NCT Number: NCT03037138
Hemodialysis patients frequently complain of postdialysis fatigue and washed-out feeling. The aim of this study is to use blood flow rate (BFR) profiling to mitigate postdialysis washed-out state.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Hemodialysis patients who complain of the postdialysis washed-out state were recruited. blood flow rate was altered to be 350 ml/min in the first hour of the session then decreased by 50 ml/min hourly for the 4-hour dialysis session. blood flow rate profiling was continued for 9 dialysis sessions (21 Days). Patients were asked to grade their washed-out state on a scale from 1 (no washed-out state) to 5 (severe washed-out state) before and after blood flow rate profiling. Paired t=-test and Wilcoxon Signed Ranks Test were used in appropriate context to compare washed out scale before and after together with urea reduction rate and other blood chemistry tests.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Blood flow rate profiling during dialysis session
Time frame: after 9 modified dialysis session (21 dyas from start of study)
Scale of washed-out degree after dialysis
Time frame: after 9 modified dialysis session (21 dyas from start of study)
change in urea reduction rate after use of blood flow rate profiling
Benha University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03390933
Behavior, Behavioral Symptoms
Cleveland, Ohio, United States
View Trial DetailsNCT03773991
Chronic Disease, Chronic Heart Disease
London, Ontario, Canada
View Trial DetailsNCT03856151
Hemodialysis-Induced Symptom, Intra-dialytic Hypotension
Keelung, Taiwan
View Trial DetailsNCT03456414
Behavior, Chronic Disease
Manises, Valencia, Spain
View Trial Details